The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 04, 2025
Filed:
Mar. 29, 2018
Applicant:
Demao Yang, Mountain View, CA (US);
Inventor:
Demao Yang, Mountain View, CA (US);
Assignee:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/145 (2006.01); A61K 40/10 (2025.01); A61K 40/22 (2025.01); A61K 40/41 (2025.01); A61P 3/10 (2006.01); A61P 5/48 (2006.01); C12N 5/0786 (2010.01);
U.S. Cl.
CPC ...
A61B 5/145 (2013.01); A61K 40/10 (2025.01); A61K 40/22 (2025.01); A61K 40/412 (2025.01); A61K 40/414 (2025.01); A61K 40/416 (2025.01); A61P 3/10 (2018.01); A61P 5/48 (2018.01); C12N 5/0645 (2013.01); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05);
Abstract
Materials and methods of treating a patient with type 2 diabetes mellitus, metabolic syndrome, obesity, infertility, high blood pressure, hyperthyroidism, and hypothyroidism, hyperlipidaemia, osteoporosis, osteoarthritis, hypoadrenalism, polycystic ovary syndrome, or Parkinson's disease comprising administering a therapeutically effective amount of ex vivo cultured activated peripheral blood mononuclear cells (PBMCs) to the patient. The ex vivo cultured activated cells are activated and cultured in a presence of a cytokine and may be autologous or allogeneic relative to the patient.